Clinical Outcomes for Breast Cancer Patients Undergoing Mastectomy and Reconstruction with Use of DermACELL, a Sterile, Room Temperature Acellular Dermal Matrix

Table 1

Patient overview and results.

Patient number	Age (yrs)	Postop. chemotherapy	Post-ADM implant radiation	Uni- or bilateral	Duration of implant prior to 2nd stage (wks)	Expander size	Implant size	Nipple/Areola reconstruction	Surgical site infection	Seroma
1	46	Yes	No	Bilateral	16	550 cc	700 cc	Yes	No	—
2	55	No	No	R only	6	450 cc	500 cc	Yes	No	—
3	60	No	No	Bilateral	16	450 cc	533 cc	No	No	—
4	52	No	No	Bilateral	19	510 cc	600 cc	Yes	No	—
5	43	No	Yes	Bilateral	16	510 cc	600 cc	Yes	No	—
6	28	No	No	Bilateral	Right side TRAM* and left implant	510 cc	533 cc	Yes	No	—
7	54	No	No	Bilateral	7 weeks	800 cc	800 cc	Yes	Yes	Yes
8	43	No	No	Bilateral	14 weeks	800 cc	800 cc	Yes	No	—
9	48	Neo-adj.	Yes	Bilateral	11/4/2011 stage 1	Aborted	Aborted	Aborted	No	—
10	Excluded due to smoking	—	—	—	—	—	—	—	—	—

∗Transverse Rectus Abdominis Myocutaneous.